| Rolipram | IC50 | 403.0 [1] |
| Rolipram | Ki | 382.0 [1] |
| (R)-2-(4-Fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)nicotinamide | IC50 | 1.0 [1] |
| Roflumilast | IC50 | 0.27 [1], 0.56 [2], 0.7 [3], 1.1 [4], 460.0 [5] |
| Cilomilast | IC50 | 11.0 [1], 27.0 [2], 39.0 [3], 63.0 [4], 79.0 [5] |
| 1-[(E)-(3-Cyclopentyloxy-4-methoxyphenyl)methylideneamino]oxy-3-(2,6-dimethylmorpholin-4-yl)propan-2-ol | IC50 | 2860.0 [1], 3460.0 [2], 7090.0 [3], 7340.0 [4] |
| 4-[8-(2,1,3-Benzoxadiazol-5-yl)-1,7-naphthyridin-6-yl]benzoic acid | IC50 | 1.5 [1] |
| Zaprinast | Ki | 8760.0 [1], 50000.0 [2] |
| Piclamilast | IC50 | 0.02 [1], 0.8 [2], 2.0 [3] |
| Zardaverine | IC50 | 390.0 [1], 800.0 [2], 2000.0 [3] |
| 4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone | Ki | 50000.0 [1] |
| Unii-G6gso9sdnj | IC50 | 1.0 [1], 1.2 [2] |
| 4-[8-(3-Nitrophenyl)-1,7-naphthyridin-6-yl]benzoic Acid | IC50 | 1.0 [1] |
| 2-[(E)-(3-Cyclopentyloxy-4-methoxyphenyl)methylideneamino]oxy-1-(2,6-dimethylmorpholin-4-yl)ethanone | IC50 | 670.0 [1], 1910.0 [2] |
| 3-(3-Cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine | Ki | 141.0 [1], 172.0 [2], 2890.0 [3] |
| 6-Amino-3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-(1-hydroxy-1-methyl-ethyl)-3H-purine hydrochloride | Ki | 4.1 [1], 5.7 [2], 413.0 [3] |
| 2-[4-[2-[3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-6-imino-7H-purin-8-yl]-2-methylpropoxy]-2-(2-oxoethoxy)phenoxy]acetaldehyde | Ki | 3.7 [1], 6.6 [2], 218.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(2-methoxyphenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 5.1 [1], 7.1 [2], 255.0 [3] |
| Methyl 4-[2-[3-[(3-cyclopentyloxy-4-methoxyphenyl)methyl]-6-imino-7H-purin-8-yl]-2-methylpropoxy]benzoate | Ki | 3.0 [1], 5.5 [2], 246.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(3-fluorophenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 7.4 [1], 8.4 [2], 369.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[(2R)-1-phenoxypropan-2-yl]-7H-purin-6-imine | Ki | 590.0 [1], 640.0 [2], 4450.0 [3] |
| 4-[2-[3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-6-imino-7H-purin-8-yl]-2-methylpropoxy]benzamide | Ki | 4.9 [1], 8.0 [2], 312.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(3,4-dimethoxyphenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 7.8 [1], 15.0 [2], 2640.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[(2R)-1-(3-methoxyphenoxy)propan-2-yl]-7H-purin-6-imine | Ki | 322.0 [1], 493.0 [2], 5050.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(3-methoxyphenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 5.1 [1], 6.0 [2], 296.0 [3] |
| 4-[2-[3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-6-imino-7H-purin-8-yl]-2-methylpropoxy]benzoic acid | Ki | 4300.0 [1], 50000.0 [2] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(3,5-dimethoxyphenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 7.9 [1], 9.0 [2], 340.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[(2R)-1-(3-fluorophenoxy)propan-2-yl]-7H-purin-6-imine | Ki | 114.7 [1], 231.0 [2], 4300.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(4-methoxyphenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 5.6 [1], 8.1 [2], 347.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[2-methyl-1-[4-(trifluoromethyl)phenoxy]propan-2-yl]-7H-purin-6-imine | Ki | 9.9 [1], 10.3 [2], 580.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[2-methyl-1-(4-methylphenoxy)propan-2-yl]-7H-purin-6-imine | Ki | 6.6 [1], 7.6 [2], 347.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(3,4-difluorophenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 13.0 [1], 13.3 [2], 459.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(3,4-dichlorophenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 6.6 [1], 10.6 [2], 355.0 [3] |
| 4-[2-[3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-6-imino-7H-purin-8-yl]-2-methylpropoxy]benzonitrile | Ki | 19.4 [1], 33.4 [2], 1840.0 [3] |
| 8-[1-(4-Tert-butylphenoxy)-2-methylpropan-2-yl]-3-[(3-cyclopentyloxy-4-methoxyphenyl)methyl]-7H-purin-6-imine | Ki | 4.3 [1], 5.0 [2], 255.0 [3] |
| 8-[1-(4-Chlorophenoxy)-2-methylpropan-2-yl]-3-[(3-cyclopentyloxy-4-methoxyphenyl)methyl]-7H-purin-6-imine | Ki | 4.8 [1], 5.8 [2], 205.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[2-methyl-1-(2-thiophen-2-ylphenoxy)propan-2-yl]-7H-purin-6-imine | Ki | 6.3 [1], 7.0 [2], 412.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[2-methyl-1-[4-(trifluoromethoxy)phenoxy]propan-2-yl]-7H-purin-6-imine | Ki | 6.5 [1], 7.2 [2], 782.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[1-(2-fluorophenoxy)-2-methylpropan-2-yl]-7H-purin-6-imine | Ki | 6.8 [1], 11.0 [2], 427.0 [3] |
| 3-[(3-Cyclopentyloxy-4-methoxyphenyl)methyl]-8-[2-methyl-1-(3-thiophen-3-ylphenoxy)propan-2-yl]-7H-purin-6-imine | Ki | 6.6 [1], 9.0 [2], 2680.0 [3] |
| Moracin M | IC50 | 2900.0 [1], 2910.0 [2] |
| (S)-(+)-Rolipram | IC50 | 1000.0 [1], 1062.0 [2] |
| 2-[5-[(1S)-1-[3-Cyclopropyloxy-4-(difluoromethoxy)phenyl]-2-(1-oxidopyridin-1-ium-3-yl)ethyl]-1,3-thiazol-2-yl]-1,1,1,3,3,3-hexafluoropropan-2-ol | IC50 | 0.4 [1] |
| (cis)-4-(3,4-Dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one | IC50 | 85.0 [1], 213.0 [2] |
| 4-(3,4-Dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one | IC50 | 213.0 [1] |
| 4-(3,4-Dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one | Ki | 6.3 [1] |
| N-[4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfinylimidazol-4-yl]pyridin-2-yl]acetamide | IC50 | 800.0 [1], 1100.0 [2] |
| (4-{[2-(5-Chlorothiophen-2-Yl)-5-Ethyl-6-Methylpyrimidin-4-Yl]amino}phenyl)acetic Acid | IC50 | 1700.0 [1], 1997.0 [2] |
| 8-(3-Methoxyphenyl)-6-(pyridin-4-ylmethyl)quinoline | IC50 | 2.5 [1] |
| 4-[8-(3-Methoxy-phenyl)-[1,7]naphthyridin-6-yl]-cyclohexanecarboxylic acid | IC50 | 64.0 [1] |
| 4-[8-(3-Cyano-phenyl)-[1,7]naphthyridin-6-yl]-cyclohexanecarboxylic acid | IC50 | 41.0 [1] |
| (cis)-2-(5-Bromopentyl)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one | IC50 | 2.0 [1] |
| (cis)-2-(5-Bromopentyl)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one | Ki | 2.3 [1] |
| 2-[4-[(2-Phenyl-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-4-yl)amino]phenyl]acetic acid | IC50 | 1300.0 [1] |
| 2-[4-[(5,5-Dioxo-2-phenyl-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-4-yl)amino]phenyl]acetic acid | IC50 | 550.0 [1], 2800.0 [2] |
| N-Butyl-2-[4-[(5,5-dioxo-2-phenyl-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-4-yl)amino]phenyl]acetamide | IC50 | 180.0 [1], 260.0 [2] |
| 4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexane-1-carboxylic Acid | IC50 | 32.0 [1] |
| 1-(8-(3-Cyanophenyl)-1,7-naphthyridine-6-yl)piperidine-4-carboxylic acid | IC50 | 19.0 [1] |
| 1-(8-(3-Fluorophenyl)-1,7-naphthyridine-6-yl)piperidine-4-carboxylic acid | IC50 | 51.0 [1] |
| 4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfinylimidazol-4-yl]pyridin-2-amine | IC50 | 700.0 [1], 2400.0 [2] |
| (E)-N-[2-Chloro-3-(2,6-dimethylmorpholin-4-yl)propoxy]-1-(3-cyclopentyloxy-4-methoxyphenyl)methanimine | IC50 | 3420.0 [1], 4270.0 [2] |
| [4-[3-[(4-Phenylpyridazino[4,5-b]indolizin-1-yl)amino]propyl]piperazin-1-yl]-pyrazin-2-ylmethanone | IC50 | 100000.0 [1] |
| [4-[3-[(4-Phenylpyridazino[4,5-b]indolizin-1-yl)amino]propyl]piperazin-1-yl]-pyrazin-2-ylmethanone | Ki | 8370.0 [1] |
| [4-[3-[[4-(3-Nitrophenyl)pyridazino[4,5-b]indolizin-1-yl]amino]propyl]piperazin-1-yl]-pyrazin-2-ylmethanone | IC50 | 4900.0 [1] |
| [4-[3-[[4-(3-Nitrophenyl)pyridazino[4,5-b]indolizin-1-yl]amino]propyl]piperazin-1-yl]-pyrazin-2-ylmethanone | Ki | 147.0 [1] |
| 4-Phenyl-N-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propyl]pyridazino[4,5-b]indolizin-1-amine | IC50 | 100000.0 [1] |
| 4-Phenyl-N-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propyl]pyridazino[4,5-b]indolizin-1-amine | Ki | 59000.0 [1] |
| 4-[3-(3-Chlorophenyl)-7-methoxy-2,4-dioxopyrimido[5,4-c]quinolin-1-yl]cyclohexane-1-carboxylic acid | IC50 | 55.0 [1] |
| 3-Benzo[1,3]dioxol-5-yl-1-cyclopentyl-7-methoxy-1H-pyrimido[5,4-c]quinoline-2,4-dione | IC50 | 827.0 [1] |
| 3-(3-Chlorophenyl)-7-methoxy-1-(1-methylsulfonylpiperidin-4-yl)pyrimido[5,4-c]quinoline-2,4-dione | IC50 | 151.0 [1] |
| 1-Cyclopentyl-3-ethyl-7-propylpyrimido[5,4-c]quinoline-2,4-dione | IC50 | 25000.0 [1] |
| 3-(3-Chlorophenyl)-7-methoxy-1-[(3S)-1-methylsulfonylpyrrolidin-3-yl]pyrimido[5,4-c]quinoline-2,4-dione | IC50 | 163.0 [1], 206.0 [2] |
| 1-Cyclopentyl-3-ethyl-7-propan-2-ylpyrimido[5,4-c]quinoline-2,4-dione | IC50 | 25000.0 [1] |
| 1-Cyclopentyl-7-methoxy-3-m-tolyl-1H-pyrimido[5,4-c]quinoline-2,4-dione | IC50 | 338.0 [1] |
| 3-(3-Chlorophenyl)-1-(1-ethylsulfonylpiperidin-4-yl)-7-methoxypyrimido[5,4-c]quinoline-2,4-dione | IC50 | 59.0 [1] |
| 3-(3-Chlorophenyl)-7-methoxy-1-[1-(methylsulfonylmethylsulfonyl)piperidin-4-yl]pyrimido[5,4-c]quinoline-2,4-dione | IC50 | 80.0 [1] |
| 1-Cyclopentyl-7-methoxy-3-(4-methyl-thiophen-2-yl)-1H-pyrimido[5,4-c]quinoline-2,4-dione | IC50 | 616.0 [1] |
| 7-Chloro-1-cyclopentyl-3-ethylpyrimido[5,4-c]quinoline-2,4-dione | IC50 | 25000.0 [1] |
| N-[4-[3-(3-Chlorophenyl)-7-methoxy-2,4-dioxopyrimido[5,4-c]quinolin-1-yl]cyclohexyl]methanesulfonamide | IC50 | 73.0 [1] |
| Sildenafil | IC50 | 20000.0 [1] |
| 3-Isobutyl-1-methylxanthine | IC50 | 38000.0 [1] |
| Clioquinol | IC50 | 10000.0 [1] |
| CID 14521039 | IC50 | 20000.0 [1] |
| Ibudilast | IC50 | 166.0 [1] |
| Morusin | IC50 | 900.0 [1] |
| Crisaborole | IC50 | 55.0 [1] |
| Cipargamin | IC50 | 10000.0 [1] |
| 4-(2-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-phenylethyl)pyridine | IC50 | 2.1 [1] |
| 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol | IC50 | 10000.0 [1] |
| N,N,2-Trimethyl-5-nitrobenzenesulfonamide | IC50 | 1280.0 [1] |
| (R)-(-)-Rolipram | IC50 | 622.0 [1] |
| Mulberrin | IC50 | 310.0 [1] |
| Licoflavone C | IC50 | 630.0 [1] |
| Moracin C | IC50 | 26000.0 [1] |
| (2S,3R)-3-(6-Amino-9H-purin-9-yl)nonan-2-ol | IC50 | 16000.0 [1] |
| Leniolisib | IC50 | 4700.0 [1] |
| 1-(4-((3'-Chloro-6-methoxy-[1,1'-biphenyl]-3-yl)methyl)phenyl)urea | IC50 | 27.0 [1] |
| (R)-5-(6-Cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamide | IC50 | 900.0 [1] |
| Cudraflavone C | IC50 | 260.0 [1] |
| Eggmanone | IC50 | 380.0 [1] |